Prevalence of Premenstrual Syndrome in Women of Reproductive Age (Sd-Premens)

Université de Reims Champagne-Ardenne

Status: Not yet enrolling

Conditions: Premenstrual Syndrome

Treatments: Other: Data collection

Study type: Observational

Funder types: Other

Identifiers

NCT06117215

2023_RIPH_014_Sd-Premens

Details and patient eligibility

About

The menstrual cycle is a recurring process in the lives of women from puberty until menopause. This cycle can cause various discomforts, including premenstrual syndrome.

Described differently, premenstrual syndrome is a collection of physical and psychological symptoms that occur during the luteal phase of the menstrual cycle and subside upon the arrival of menstruation. This definition is conditioned by the existence of a free interval of at least one week between the end of the period and the appearance of these symptoms, as well as a global impairment of functioning and quality of life for women.

The impact on the personal, social, and professional lives of affected women, as well as the pain and discomfort it causes, may be perceived as insignificant or normal by women. Therefore, few women report the existence of these disorders to healthcare professionals. As the subject is not approached, these women are not taken care of even though therapeutic solutions could be proposed.

This pathology affects a large number of women, but its prevalence differs greatly depending on the studies conducted on the subject, suggesting a lack of knowledge of this syndrome.

Full description

The main aim is to describe the prevalence of premenstrual syndrome among women of reproductive age.

Enrollment: 2,000 estimated patients

Sex: Female

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• women in childbearing age, i.e., menstrual or secondary amenorrhoea, non-menopausal
• Over 18 years of age
• Agreeing to participate in the study

Exclusion criteria

• Menopause
• Having had a hysterectomy
• With primary amenorrhea
• Protected by law
• Refusing to participate in the study

Trial design

2,000 participants in 1 patient group

women of reproductive age

Description:

women of reproductive age

Treatment:

Other: Data collection